company background image
4550 logo

Nissui Pharmaceutical TSE:4550 Stock Report

Last Price

JP¥1.71k

Market Cap

JP¥16.9b

7D

0.2%

1Y

77.1%

Updated

16 Nov, 2022

Data

Company Financials

Nissui Pharmaceutical Co., Ltd.

TSE:4550 Stock Report

Market Cap: JP¥16.9b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

4550 Stock Overview

Nissui Pharmaceutical Co., Ltd. produces, sells, imports, and exports culture media and diagnostics for medical institutions, research organizations, and food industries in Japan and internationally. More details

4550 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends3/6

Risk Analysis

Earnings have declined by 11.2% per year over past 5 years

Unstable dividend track record


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Nissui Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Nissui Pharmaceutical
Historical stock prices
Current Share PriceJP¥1,714.00
52 Week HighJP¥1,745.00
52 Week LowJP¥937.00
Beta-0.22
1 Month Change0.29%
3 Month Change0.29%
1 Year Change77.07%
3 Year Change32.36%
5 Year Change16.52%
Change since IPO58.83%

Recent News & Updates

Recent updates

Shareholder Returns

4550JP Medical EquipmentJP Market
7D0.2%-1.7%0.1%
1Y77.1%-8.5%0.3%

Return vs Industry: 4550 exceeded the JP Medical Equipment industry which returned -4.1% over the past year.

Return vs Market: 4550 exceeded the JP Market which returned -1.1% over the past year.

Price Volatility

Is 4550's price volatile compared to industry and market?
4550 volatility
4550 Average Weekly Movement0.7%
Medical Equipment Industry Average Movement5.0%
Market Average Movement5.5%
10% most volatile stocks in JP Market9.4%
10% least volatile stocks in JP Market3.1%

Stable Share Price: 4550 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4550's weekly volatility (1%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1935239Tokuya Onowww.nissui-pharm.co.jp

Nissui Pharmaceutical Co., Ltd. produces, sells, imports, and exports culture media and diagnostics for medical institutions, research organizations, and food industries in Japan and internationally. It offers in vitro diagnostics and medical devices; culture media for microbiological testing; products for antimicrobial susceptibility tests, microorganism identification, and immunological tests; and quality control serum, which is used for ensuring the accuracy of clinical diagnoses. In addition,, the company provides microbiological testing products for food poisoning detection; immunosorbent assays for the detection of allergies to food items, such as eggs, wheat, milk, shrimp, crabs, buckwheat, peanuts, etc.; and culture media and reagents for regenerative medicine.

Nissui Pharmaceutical Co., Ltd. Fundamentals Summary

How do Nissui Pharmaceutical's earnings and revenue compare to its market cap?
4550 fundamental statistics
Market capJP¥16.87b
Earnings (TTM)JP¥1.01b
Revenue (TTM)JP¥17.18b

16.7x

P/E Ratio

1.0x

P/S Ratio

Is 4550 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4550 income statement (TTM)
RevenueJP¥17.18b
Cost of RevenueJP¥11.72b
Gross ProfitJP¥5.46b
Other ExpensesJP¥4.45b
EarningsJP¥1.01b

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)102.73
Gross Margin31.80%
Net Profit Margin5.88%
Debt/Equity Ratio0%

How did 4550 perform over the long term?

See historical performance and comparison

Dividends

2.3%

Current Dividend Yield

77%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/11/16 10:22
End of Day Share Price 2022/11/10 00:00
Earnings2022/09/30
Annual Earnings2022/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nissui Pharmaceutical Co., Ltd. is covered by 1 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullCompany Forecast